Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co LtdfiledCriticalGrelan Pharmaceutical Co Ltd
Priority to JP7997776ApriorityCriticalpatent/JPS537688A/en
Publication of JPS537688ApublicationCriticalpatent/JPS537688A/en
PURPOSE: To prepare the title compound, useful as low toxic antitumors, in high yield with simple operations by the reaction of 5-cluorouracil, which is stable to moisture, heat, etc. with carboxylic acid ester derivatives.
COPYRIGHT: (C)1978,JPO&Japio
JP7997776A1976-07-071976-07-07Preparation of n1-(2-tetrahydrofuranyl)-5-fluorouracil
PendingJPS537688A
(en)